<DOC>
	<DOCNO>NCT02342925</DOCNO>
	<brief_summary>This single-center , non-randomized , open-label , two treatment , two period , fix sequence crossover study investigate effect RG1662 treatment activity key renal transporter healthy male female participant use metformin . The effect RG1662 renal function parameter also explore .</brief_summary>
	<brief_title>A Study Effect RG1662 Metformin Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy male female participant , age 18 60 year , inclusive A body mass index 18 32 kg/m2 , inclusive Informed consent agreement comply study restriction A history epilepsy , convulsion significant head injury Significant history drug allergy know hypersensitivity ingredient study treatment Pregnant lactating Impaired renal function clinically relevant hematuria A history lactic acidosis , risk factor lactic acidosis Any clinically relevant abnormality , concomitant disease ongoing medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>